- €12.72bn
- €17.58bn
- €3.54bn
Sartorius, Sartorius Stedim Biotech jump after Q4 earnings beat
Barclays cautious on European pharma in H1, sees re-rating chance in H2
Brief: Sartorius Michael Grosse To Become CEO
Europe's vaccine makers fall as Trump picks RFK Jr to lead top US health agency (updated)
Danaher beats quarterly profit estimates on strong demand for bioprocessing unit
US life sciences firms get lift from Sartorius' results
Newscasts - Europe Today: The ECB looks set for a second straight rate cut
Germany's Merck jumps after raised electronics guidance, Sartorius read-across
Live Markets: Earnings lift the STOXX, banks buoyant
Germany's Merck open to more M&A for its Life Science division (updated)
Sartorius rises as Bioprocessing orders boost 9M results
Brief: Sartorius Confirms FY Outlook
Brief: Sartorius 9M EBITDA EUR 686.5 Million
Stifel adjusts ratings on European pharma; downgrades Sartorius, Siegfried ahead of H2
Europe Research Roundup: Alstom, Siemens, Tesco
Brief: Sartorius AG - Sartorius And G-Con Collaborate To Deliver Sustainable, Flexible Cgmp Facilities Faster
RBC ups Sartorius, Stedim Biotech as shares underperformance provides an opportunity
Europe Research Roundup: Draegerwerk, Hikma, Novartis
Europe Research Roundup: AB Foods, Bunzl, Barratt